Exon 6 was replaced with one in which three silent mutations introduced a Bsp1286I restriction site for diagnostic purposes and two mutations resulted in the amino acid substitution of alanine for isoleucine at position 130 (I130A). Cre-mediated recombination removed the floxed neo cassette inserted downstream of the modified exon 6.